We examined the knockdown efficiency of three shRNAs to silence FERMT1 in 293T cells, and most effective one was selected for transfection in U-251 MG and T98G glioma cancer cells (Fig. 2A). This evidence concerns the gene FERMT1 and central nervous system cancer.